"NO FIGURA ESPAÑA" VERALIPRIDE Y AUN CON ESTOS DATOS "LO AUTORIZAN" Y CON QUÉ PROSPECTO.

Monograph Number: 0009948 Title: Veralipride CAS Registry Number: 66644-81-3 CAS Name: 5-(Aminosulfonyl)-2,3-dimethoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]benzamide Additional Names: N-[(1-allyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-veratramide Manufacturers' Codes: LIR-1660 Trademarks: Agreal (Sanofi-Aventis); Agradil (Sanofi-Aventis) Molecular Formula: C17H25N3O5S Molecular Weight: 383.46 Percent Composition: C 53.25%, H 6.57%, N 10.96%, O 20.86%, S 8.36% Literature References: Dopamine D2-receptor antagonist. Prepn: NL pat. 7707982 (1978 to Soc. d'Etudes Sci. Ind. de l'Ile-de-France), C.A. 89, 30768 (1978). Pharmacological studies: P. Bouyard et al., Sem. Hop. 56, 1475 (1980); J. C. Czyba, ibid. 1483. Clinical studies: R. Renaud, J. Macler, ibid. 57, 353 (1981); S. Angeli, P. Fougere, ibid. 58, 111 (1982). Review of safety and tolerability: V. De Leo et al., Expert Opin. Drug Saf. 5, 695-701 (2006). Therap-Cat: Treatment of menopausal disorders. Keywords: Dopamine Receptor Antagonist.Monograph